D M Danilenko
Overview
Explore the profile of D M Danilenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
859
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrova P, Konovalova N, Danilenko D, Vasilieva A, Eropkin M
Vopr Virusol
. 2022 Dec;
63(4):160-164.
PMID: 36494971
Human A (H3N2) influenza viruses are distinguished by a high rate of evolution and regularly cause epidemics around the world. Their ability to adapt and to escape from the host's...
2.
Danilenko D, Eropkin M, Leonenko V, Konovalova N, Petrova P, Zheltukhina A, et al.
J Virol Methods
. 2021 Apr;
293:114170.
PMID: 33901526
This paper presents comparative hemagglutination inhibition (HI) assay data obtained using ferret or rat antisera to analyze influenza viruses. The results indicate that rat antisera can be successfully applied both...
3.
Tang M, Keir M, Erickson R, Stefanich E, Fuh F, Ramirez-Montagut T, et al.
Aliment Pharmacol Ther
. 2018 Mar;
47(11):1440-1452.
PMID: 29601644
Background: Novel treatments with superior benefit-risk profiles are needed to improve the long-term prognosis of patients with inflammatory bowel disease (IBD). Etrolizumab-a monoclonal antibody that specifically targets β7 integrins-is currently...
4.
Petrova E, Sukhovetskaia V, Pisareva M, Maiorova V, Sverlova M, Danilenko D, et al.
Klin Lab Diagn
. 2016 Mar;
60(11):44-9.
PMID: 26999865
The analysis was implemented concerning diagnostic parameters of commercial quick tests (immune chromatographic tests BinaxNOW Influenza A&B and BinaxNow RSV Alere, Scarborough Inc., USA) under detection of antigens of influenza...
5.
Smirnova T, Danilenko D, Ilyinskaya E, Smirnova S, Eropkin M
Tsitologiia
. 2015 Nov;
57(7):526-32.
PMID: 26591065
The severity of disease caused by influenza A infection depends not only on biological characteristics of the virus but also on the number of viral particles than penetrate the body....
6.
Danilenko D, Smirnova T, Gudkova T, Prokopets A, Bildanova E, Kadyrova R, et al.
Vopr Virusol
. 2014 Jul;
59(2):40-5.
PMID: 25069285
Study of effectiveness of CaCo-2 cell line for influenza virus isolation was carried out. It was shown that the properties of this cell line strongly depended on the source of...
7.
Danilenko D, Nambiar P, Cesta M
Vet Pathol
. 2014 Jan;
51(2):541-4.
PMID: 24442576
No abstract available.
8.
Smirnova T, Danilenko D, Slita A
Tsitologiia
. 2013 May;
55(2):92-100.
PMID: 23718071
Influenza remains a significant social threat especially regarding the emergence of new mutant or reassortant strains. Measures of prophylaxis do not provide complete and stable protection from infection and the...
9.
Lobova T, Prokopets A, Komissarov A, Danilenko D, Paiankova A, Sukhovetskaia V, et al.
Vopr Virusol
. 2013 Mar;
57(6):22-6.
PMID: 23477250
Specific traits of influenza B viruses circulation in Russia and worldwide in 2005-2012 were studied and the amount of influenza B viruses in the whole population of influenza viruses isolated...
10.
[Development of influenza surveillance in Russia in the system of the WHO national influenza center]
Sominina A, Grudinin M, Eropkin M, Smorodintseva E, Pisareva M, Konissarov A, et al.
Vopr Virusol
. 2013 Mar;
57(6):17-21.
PMID: 23477249
Analysis of development influenza activity season 2010-2011 is presented. Significant participation of influenza A(H1N1)pdm09 virus and influenza B of Victoria lineage virus in the epidemic morbidity structure with minor participation...